or Try an Advanced Search...

    Technical Analysis for VERA - Vera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 41.29 4.51% 1.78
    VERA closed down 4.52 percent on Tuesday, April 30, 2024, on approximately normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical VERA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 4.51%
    Multiple of Ten Bearish Other 4.51%
    Wide Bands Range Expansion 4.51%
    Crossed Above 20 DMA Bullish -0.22%
    Wide Bands Range Expansion -0.22%
    NR7 Range Contraction 4.14%
    Multiple of Ten Bearish Other 4.14%
    Wide Bands Range Expansion 4.14%
    Wide Bands Range Expansion 6.72%
    Gapped Down Weakness 6.72%
    Older End-of-Day Signals for VERA ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    Rose Above 20 DMA about 1 hour ago
    Rose Above Previous Day's High about 1 hour ago
    Rose Above 10 DMA about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VERA Chart by TradingView
    Basic chart:

    Profile

    Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Health Care

    Is VERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 Health Care Roundup: Market Talk
    Apr 13 Could This Stock Be the Next Biotech Buyout?
    Apr 12 Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
    Apr 11 Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
    Apr 5 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
    Apr 3 Vera Therapeutics: Waiting For A Pullback
    Apr 2 Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
    Mar 20 Vera Therapeutics GAAP EPS of -$2.25 misses by $0.07
    Mar 20 Vera Therapeutics: Q4 Earnings Insights
    Mar 20 Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    See more VERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 50.78
    52 Week Low 6.7
    Average Volume 1,037,949
    200-Day Moving Average 24.03
    50-Day Moving Average 42.96
    20-Day Moving Average 40.70
    10-Day Moving Average 39.53
    Average True Range 3.06
    RSI (14) 46.52
    ADX 12.79
    +DI 25.42
    -DI 23.56
    Chandelier Exit (Long, 3 ATRs) 41.48
    Chandelier Exit (Short, 3 ATRs) 45.03
    Upper Bollinger Bands 47.21
    Lower Bollinger Band 34.18
    Percent B (%b) 0.41
    BandWidth 32.00
    MACD Line -0.61
    MACD Signal Line -0.46
    MACD Histogram -0.1418
    Fundamentals Value
    Market Cap 2.12 Billion
    Num Shares 53.7 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -13.81
    Price-to-Sales 0.00
    Price-to-Book 16.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 43.86
    Resistance 3 (R3) 44.12 42.94 43.14
    Resistance 2 (R2) 42.94 41.83 42.81 42.89
    Resistance 1 (R1) 41.22 41.14 40.63 40.96 42.65
    Pivot Point 40.04 40.04 39.74 39.91 40.04
    Support 1 (S1) 38.32 38.93 37.73 38.06 36.37
    Support 2 (S2) 37.14 38.24 37.01 36.13
    Support 3 (S3) 35.42 37.14 35.89
    Support 4 (S4) 35.16